Lyra Therapeutics, Inc (LYRA) insider trading

Every open-market stock purchase and sale by Lyra Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $535K over the last 12 months (4 sales). No open-market buys.
  • Last insider buy: Harlan Waksal (Chair), $74.1K, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $535K (4 sales). Last close $0.70 on Jun 4, 2026.

Recent LYRA insider trades

DateInsiderTradeValue
May 14, 2026W Bradford Smith (Insider)Sold (not open market)—
Apr 1, 2026Jason Cavalier (Insider)Sold (not open market)—
Apr 1, 2026Maria Palasis (Insider)Sold (not open market)—
Jan 6, 2026Maria Palasis (CEO)Sold$5.7K
Jan 6, 2026Jason Cavalier (CFO)Sold$2.6K
Nov 13, 2025Perceptive Advisors LLC (Insider)Sold$112K
Nov 13, 2025Perceptive Advisors LLC (Insider)Sold$12.5K
Nov 12, 2025Perceptive Advisors LLC (Insider)Sold$31.9K
Nov 12, 2025Perceptive Advisors LLC (Insider)Sold$3.6K
Nov 11, 2025Perceptive Advisors LLC (Insider)Sold$20.6K
Nov 11, 2025Perceptive Advisors LLC (Insider)Sold$2.3K
Nov 10, 2025Perceptive Advisors LLC (Insider)Sold$75.5K
Nov 10, 2025Perceptive Advisors LLC (Insider)Sold$8.5K
Nov 7, 2025Perceptive Advisors LLC (Insider)Sold$84.2K
Nov 7, 2025Perceptive Advisors LLC (Insider)Sold$9.5K
Nov 6, 2025Perceptive Advisors LLC (Insider)Sold$150K
Nov 6, 2025Perceptive Advisors LLC (Insider)Sold$16.8K

Who's trading LYRA

Get free alerts when an insider at Lyra Therapeutics, Inc files a new trade →